Tissue plasminogen activator does not benefit most eligible patients with stroke.
Maarten G
MG
Lansberg
Neil E
NE
Schwartz
D018849:Controlled Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D020766:Intracranial Embolism / Q000188:drug therapy*; D009460:Neurologic Examination / Q000187:drug effects; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator